Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.46 |
| ▸ | FABP7 | O15540 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CASP3 | P42574 | 2/20 | 0.42 |
| ▸ | MDM4 | O15151 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL401725 | 0.88 | KMT2A (0.67) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL31031957 | 0.88 | KMT2A (0.67) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL29367495 | 0.88 | KMT2A (0.67) | KMT2AEPHX2FABP5FABP7CA1 | |
| Hydrochloric Acid SCHEMBL1595146 | 0.86 | KMT2A (0.65) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL15058849 | 0.86 | KMT2A (0.55) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL29537880 | 0.84 | KMT2A (0.52) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL8612414 | 0.83 | KMT2A (0.54) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL44676 | 0.82 | KMT2A (0.58) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL7767154 | 0.81 | FABP5 (0.54) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL29598813 | 0.81 | FABP5 (0.54) | KMT2AEPHX2FABP5FABP7CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102319437-A | Polymer conjugate with interferon-beta of enhanced biological availability | MOUNTAIN VIEW PHARMACEUTICALS | 2012-01-18 | — | — | CN | disclosed |
| CN-1852732-A | Polymer conjugates of interferon-beta with enhanced biological utility | MOUNTAIN VIEW PHARMACEUTICALS (US) | 2006-10-25 | — | — | CN | disclosed |